Scientific Advisory Council
StemSave’s Scientific Advisory Council includes leading stem cell researchers from major universities and research centers. With our deep and profound understanding of stem cells, StemSave’s team of dedicated professionals are on the cutting edge of stem cell, regenerative medicine and healthspan research.
Our mission is to make the benefits of stem cell science conveniently and affordably available to your family. As part of our mission, we’ll keep you updated on the latest stem cell breakthroughs by our Advisory members as well as researchers and medical professionals from around the world.
Dr. Jeremy J. Mao, DDS, Ph.D is an Oral Surgeon and research scientist. He is the Director of the Tissue Engineering and Regenerative Medicine Laboratory (TERML) at Columbia University, as well as a Professor of Dental Medicine and Zegarelli Endowed Chair at the University. Dr. Mao is also a Director of the Center for Craniofacial Regeneration.
Dr. Mao has published over 300 scientific papers, book chapters, conference proceedings and other articles in the areas of tissue engineering, stem cells and regenerative medicine.
He also serves on the editorial boards of several scientific journals, and as a consultant for the National Institutes of Health, the National Science Foundation and dozens of other private and international grant agencies.
Dr. Mao's laboratory at Columbia University holds dozens of patents in the areas of stem cell biology, tissue engineering and regenerative medicine. Dr. Mao has given over 340 plenary, keynote, endowed and invited lectures in the fields of stem cell biology and tissue engineering.
David A. Matzilevich, MD, is a leading stem cell researcher whose work focuses on stem cell based therapeutic approaches. Prior to dedicating himself to stem cell research, Dr. Matzilevich was a faculty member at McLean Hospital and Harvard Medical School. His work there involved identification of molecular endophrenotypes and suseptibility genes involved in the pathogensis of Schizophrenia and Bipolar Disorder.
Dr. Matzilevich received his MD, PhD from the Imperial College of Science, Technology and Medicine in London, UK. Following his studies in London, Dr. Matzilevich received a fellowship in the Department of Pathology at Tufts Medical School in Boston and went on to the University of Texas Medical Center at Houston in the Department of Neuroscience and the Keck Center for Neurology and Neurosurgery where he worked on the use of adult stem cells for the treatment of neurological disorders. Dr. Matzilevich is currently involved in several clinical trials using adult stem cells for treating neurological disorders.
Dr. Matzilevich lectures extensively on stem cells, holds several patents and has published over 30 peer reviewed articles and papers. Dr. Matzilevich appears frequently on TV, radio, industry and scientific journals as well as mainstream print media as an acknowledged stem cell expert.
George T.-J. Huang, DDS, MSD, DSc is the Director of Stem Cells and Regenerative Therapies and Professor at the University of Tennessee Health Science Center College of Dentistry, Department of Bioscience Research.
Prior to his Directorship, Dr. Huang was the Chair and Herbert Schilder Professor in Endodontics and Director, Postgraduate Program in Endodontics of Boston University’s Henry M. Goldman School of Dental Medicine. Dr. Huang has published more than 100 research articles, review articles, book chapters and abstracts including papers in Stem Cells and Development, Tissue Engineering, Regenerative Medicine, Infection and Immunity, Human Gene Therapy, Journal of Dental Research and Journal of Endodontics; book chapter in Principles of Regenerative Medicine, etc.
His research has been funded by various sources including NIH and AAE Foundation. His current research interest is in the area of stem cells and regenerative medicine with particular emphasis on the generation and characterization of induced pluripotent stem (iPS) cells from dental stem cells, which may prove to be an indefinite cell source for tissue regeneration, and stem cell-based dental tissue regeneration utilizing adult stem cells and tissue engineering methods to regenerate lost tooth structure.
The focus is on characterizing dental stem cells including dental pulp stem cell (DPSCs), stem cells from apical papilla (SCAP), stem cells from human exfoliated teeth (SHED), and periodontal ligament stem cells (PDLSCs) and utilizing these stem/progenitor cells to regenerate dental tissues including dental pulp, dentin, cementum and periodontal ligament.